Armata Pharmaceuticals, Inc. (ARMP) › Cash & EquivalentsArmata Pharmaceuticals, Inc. (ARMP) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2012: $862.0K2013: $20.36M2014: $6.58M2015: $9.37M2016: $5.71M2017: $5.13M2018: $9.66M2019: $6.03M2020: $9.65M2021: $10.29M2022: $14.85M2023: $13.52M2024: $9.29M2025: $8.69M$8.69M2012Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$8.69M-6.5%2024$9.29M-31.3%2023$13.52M-8.9%2022$14.85M+44.4%2021$10.29M+6.6%2020$9.65M+59.9%2019$6.03M-37.6%2018$9.66M+88.3%2017$5.13M-10.1%2016$5.71M-39.1%2015$9.37M+42.4%2014$6.58M-67.7%2013$20.36M+2261.4%2012$862.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share